68
Participants
Start Date
June 27, 2014
Primary Completion Date
January 22, 2020
Study Completion Date
January 22, 2020
MLN9708
"Dose Escalation Phase - Starting Dose of MLN9708: 3 mg by mouth on day 1, 8 and 15.~Dose Expansion Phase Starting Dose of MLN9708: Maximum tolerated dose from Dose Escalation Phase."
Vorinostat
"Dose Escalation Phase - Starting Dose of Vorinostat: 100 mg by mouth twice a day, total of 200 mg/day Days 1 to 21.~Dose Expansion Phase Starting Dose of Vorinostat: Maximum tolerated dose from Dose Escalation Phase."
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Millennium Pharmaceuticals, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER